Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03121794 · ClinicalTrials.gov registry record

Ultrasonographic Identification of the Proximal Humerus Landmarks

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
30
Enrollment target

NCT03121794: Completed study, sponsored by The Cleveland Clinic.

NCT03121794 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03121794 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

Evaluate whether discrete landmarks of the proximal humerus can be identified using ultrasound in patients with various body habitus and BMI.

Primary Outcome

Two investigators will perform an ultrasonographic exam on each patient, with one investigator examining each side of the body. Each investigator will aim to identify 6 anatomical landmarks: 1. The humeral shaft, 2. The surgical neck of the humerus, 3. The lesser tubercle, 4. The greater tubercle, 5. The intertubercular sulcus 6. The target site in the greater tubercle for needle insertion. Each side will receive a score ranging from 0 to 6 corresponding to the number of landmarks correctly ide

Interventions

  • PROCEDURE Ultrasonographic exam
  • DEVICE ultrasound machine

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-04-01
Est. Completion 2020-07-07
The Cleveland Clinic

688 total trials

What the finished NCT03121794 record still lists

NCT03121794 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Ultrasonographic exam is the first listed.

NCT03121794 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03121794 about?

NCT03121794 is a clinical study titled "Ultrasonographic Identification of the Proximal Humerus Landmarks". Evaluate whether discrete landmarks of the proximal humerus can be identified using ultrasound in patients with various body habitus and BMI.

What is the current status of trial NCT03121794?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-04-01. Estimated completion is 2020-07-07.

What interventions are being tested in trial NCT03121794?

The interventions under investigation include: Ultrasonographic exam (PROCEDURE), ultrasound machine (DEVICE).

Who is sponsoring clinical trial NCT03121794?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03121794, the US trial registry maintained by the National Library of Medicine. NCT03121794 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.